Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Prime Therapeutics history
Prime Therapeutics company history timeline
2004: Health Care Services Corporation (HCSC) joins Prime as an equity owner.
2006: Florida Blue joins Prime as an equity owner.
2006: Prime is the seventh largest PBM serving the new Medicare Part D program.
2007: Prime is among the first PBMs to earn URAC accreditation, enabling clients to delegate PBM functions to Prime.
2008: PrimeCares formalizes our support for our employees and communities.
By 2010, Prime had 12 Blue Plan client-owners and 17 million members.
2010: Prime introduces “be well” for employees, offering wellness screenings, health coaching, classes and more.
2010: BCBS of Alabama joins Prime as an equity owner.
2011: Prime introduces CareCentered Contracting™, an innovative contracting program with drug makers.
2012: BCBS of North Carolina joins Prime as an equity owner.
2013: Years before the opioid crisis makes headlines, Prime and Florida Blue develop an award-winning controlled substance (CS) program that saves lives.
2014: Integrated care reduces medical costs by 11%, according to a joint study by the Blue Cross Blue Shield Association and Prime.
2015: Prime is the largest PBM serving members of the (HIM) created under the Affordable Care Act.
2015: Prime’s award-winning Specialty Drug Watch List prepares clients for the impact of new, high-costs drugs using client-specific integrated data.
2015: Prime launches Best in Care™, a set of drug management programs for high-cost drugs.
2015: Prime Analytics™ provides clients with on-demand access to daily reports and interactive dashboards to analyze drug spend and trend.
2016: BCBS of Rhode Island joins Prime as an equity owner.
2017: Prime earns National Committee for Quality Assurance (NCQA) certification for utilization management and health information products.
2017: Cambia/Regence BCBS joins Prime as an equity owner.
2017: To accommodate growth and improve efficiency, Prime breaks ground on Prime Landing, a state-of-the art corporate headquarters in Eagan, Minnesota.
2018: Prime’s award-winning Controlled Substance Management Program contributes to a 79% decline in the number of high-risk opioid users over the previous five years.
2019: Specialty MonitorTM, a powerful analytics tool, gives clients self-service access to their integrated specialty drug data.
March 2020: Leveraging artificial intelligence technology from SAS, Prime’s award-winning enhanced fraud, waste and abuse (FWA) program saves clients $280 million in 12 months.
August 2020: The Prime Together Foundation is created to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger.
May 2021: The first phase of MedDriveTM, a first-of-its kind medical drug management program aligned with our Blue Plan clients, emphasizes biosimilars, predictive analytics and the combined strength of our clients to improve management of medical drug spend.
May 2021: Insights+, a highly consultative data and analytics platform integrating medical and pharmacy data, succeeds Specialty Monitor and expands service to include select employer group clients.
July 2021: Prime’s innovative Hub + Home strategy defines and supports the key places where Prime employees work: Prime Landing, the office hub, home offices for remote work, and the virtual workplace that wraps around all locations.
December 2021: The Prime Together Foundation awards its first grants to support community organizations working to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger.
January 2022: Prime earns perfect score on Human Rights Campaign Foundation’s 2022 Corporate Equality Index.
January 2022: Prime Landing reopens for employees who wish to work in the office.
April 2022: ClearStone Solutions selects Prime to administer Medicare Part D pharmacy benefits beginning Jan.
May 2022: The first phase of MedDriveTM, a first-of-its kind medical drug management program aligned with our Blue Plan clients, emphasizes biosimilars, predictive analytics and the combined strength of our clients to improve management of medical drug spend.
May 2022: Prime enters into a definitive agreement to acquire Magellan Rx for $1.35 billion.
Rate Prime Therapeutics' efforts to communicate its history to employees.
Prime Therapeutics jobs
Do you work at Prime Therapeutics?
Does Prime Therapeutics communicate its history to new hires?
Prime Therapeutics competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Solstice Benefits | 1998 | $7.9M | 130 | - |
| Blue Cross Blue Shield of North Carolina | 1933 | $4.7B | 4,397 | 26 |
| Unitedheath Group | 1977 | $1.4B | 1,800 | 137 |
| Blue Cross & Blue Shield of Mississippi | 1947 | $880.0M | 1,000 | 11 |
| Pomco | 1978 | $700.0M | 750 | - |
| Blue Cross and Blue Shield of Kansas | 1942 | $2.1B | 3,000 | 36 |
| Travel Guard | 1982 | $1.0M | 5 | - |
| Winston Benefits | 1987 | $21.0M | 174 | - |
| World Insurance Associates | 2012 | $11.3M | 3,000 | 309 |
| PacificSource Health Plans | 1933 | $5.0M | 3,000 | 88 |
Prime Therapeutics history FAQs
Zippia gives an in-depth look into the details of Prime Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Prime Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Prime Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Prime Therapeutics. The data presented on this page does not represent the view of Prime Therapeutics and its employees or that of Zippia.
Prime Therapeutics may also be known as or be related to Prime Therapeutics and Prime Therapeutics LLC.